Zoetis Inc. (NYSE:ZTS) Shares Purchased by Montag & Caldwell LLC

Montag & Caldwell LLC grew its stake in shares of Zoetis Inc. (NYSE:ZTS) by 4.1% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 123,832 shares of the company’s stock after purchasing an additional 4,934 shares during the quarter. Zoetis comprises about 4.3% of Montag & Caldwell LLC’s portfolio, making the stock its 6th biggest holding. Montag & Caldwell LLC’s holdings in Zoetis were worth $21,468,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Focus Financial Network Inc. ADV bought a new position in shares of Zoetis during the 4th quarter worth approximately $2,159,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Zoetis by 31.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after purchasing an additional 3,244,074 shares during the last quarter. Axiom Investors LLC DE raised its position in shares of Zoetis by 36.3% in the fourth quarter. Axiom Investors LLC DE now owns 594,474 shares of the company’s stock valued at $117,331,000 after purchasing an additional 158,459 shares during the period. Global Assets Advisory LLC acquired a new stake in shares of Zoetis during the 1st quarter worth about $8,831,000. Finally, Franklin Street Advisors Inc. NC lifted its stake in shares of Zoetis by 4.3% during the 1st quarter. Franklin Street Advisors Inc. NC now owns 121,024 shares of the company’s stock worth $20,478,000 after buying an additional 5,035 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the topic of several research analyst reports. Argus raised shares of Zoetis to a “strong-buy” rating in a report on Friday, August 9th. BTIG Research increased their target price on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Stifel Nicolaus reissued a “buy” rating and set a $200.00 price target on shares of Zoetis in a report on Tuesday, August 27th. Finally, Piper Sandler increased their price objective on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 14th. Nine analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Zoetis presently has an average rating of “Buy” and an average price target of $217.11.

Zoetis Stock Performance

ZTS opened at $191.09 on Monday. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92. The firm has a market cap of $86.57 billion, a P/E ratio of 36.82, a price-to-earnings-growth ratio of 2.92 and a beta of 0.88. The business’s fifty day moving average is $182.85 and its 200-day moving average is $174.14.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. The firm had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.41 earnings per share. Sell-side analysts expect that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.